Release Date: 19/02/19 11:48 Summary: First Supplementary Target Statement Price Sensitive: Yes Download Document Not available as of the moment. Download
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025